Pictet Asset Management Sa Kiniksa Pharmaceuticals, Ltd. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Pictet Asset Management Sa holds 1,517,123 shares of KNSA stock, worth $38.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,517,123
Previous 1,443,027
5.13%
Holding current value
$38.3 Million
Previous $15.5 Million
37.58%
% of portfolio
0.03%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding KNSA
# of Institutions
11Shares Held
1.89MCall Options Held
0Put Options Held
0-
Spearhead Capital Advisors, LLC Wellington, FL203KShares$5.12 Million2.82% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$997,4160.0% of portfolio
-
Barclays PLC London, X034.8KShares$880,0330.0% of portfolio
-
Birchview Capital, LP Burlington, VT30KShares$757,8000.56% of portfolio
-
Credit Suisse Ag Zurich, V828.9KShares$730,6200.0% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $871M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...